Product
Get the ingredient, exact brand, pack and authorised purpose in writing.
Injection library
Investigational combination name. CagriSema combines investigational cagrilintide with semaglutide and has been studied in the REDEFINE programme. It should not be confused with an authorised semaglutide product.
Quick facts
What it is
CagriSema combines investigational cagrilintide with semaglutide and has been studied in the REDEFINE programme. It should not be confused with an authorised semaglutide product.
No approved medical use for the combination as of this review date.
Why people search it
Combination results generate interest before regulatory review is complete. Online products using similar names may not match clinical-trial material.
Search popularity does not establish safety, quality, eligibility or availability.
Turkey context
Do not purchase a product presented as CagriSema outside a properly registered clinical trial or future authorised supply pathway.
Get the ingredient, exact brand, pack and authorised purpose in writing.
Verify the named clinician and why the medicine fits your clinical context.
Use a licensed pharmacy and keep the original carton, leaflet and receipt.
Agree who monitors treatment and supply after you return home.
Safety boundary
FDA states cagrilintide is not a component of an FDA-approved drug and cannot be used in compounding under US federal law.
Common questions
No approved medical use for the combination as of this review date.
Do not purchase a product presented as CagriSema outside a properly registered clinical trial or future authorised supply pathway.
Investigational combination name. Brand names, indications and availability vary by jurisdiction; confirm the exact product rather than relying on the ingredient name alone.
Do not buy prescription or investigational injections from social media, informal sellers or unverified websites. FDA states cagrilintide is not a component of an FDA-approved drug and cannot be used in compounding under US federal law.
Primary reference